Evidence map›Paper›PMID 42738360›Full record

ArticleCancers2026

Long-Term Outcomes and Paired Immune and Genomic Exploratory Analyses After Neoadjuvant Dose-Dense MVAC in Muscle-Invasive Bladder Cancer: A Single-Centre Case Series.

Daan De Maeseneer, Alexander Decruyenaere, Joni Van der Meulen, Siebe Loontiens, Toon Rosseel, Pieter-Jan Volders, Sofie Verbeke, Valerie Fonteyne, Charles Van Praet, Camille Berquin and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Daan De MaeseneerDepartment of Medical Oncology, Ghent University Hospital, 9000 Ghent, Belgium.ORCID 0000-0002-0339-5621
Alexander DecruyenaereDepartment of Medical Oncology, Ghent University Hospital, 9000 Ghent, Belgium.ORCID 0000-0001-6795-7606
Joni Van der MeulenMolecular Diagnostics, Ghent University Hospital, 9000 Ghent, Belgium.
Siebe LoontiensMolecular Diagnostics, Ghent University Hospital, 9000 Ghent, Belgium.
Toon RosseelDepartment of Biomolecular Medicine, Ghent University, 9000 Ghent, Belgium.
Pieter-Jan VoldersDepartment of Biomolecular Medicine, Ghent University, 9000 Ghent, Belgium.ORCID 0000-0002-2685-2637
Sofie VerbekeDepartment of Pathology, Ghent University Hospital, 9000 Ghent, Belgium.
Valerie FonteyneDepartment of Radiotherapy-Oncology, Ghent University Hospital, 9000 Ghent, Belgium.
Charles Van PraetDepartment of Urology, Ghent University Hospital, 9000 Ghent, Belgium.ORCID 0000-0002-4467-0829
Camille BerquinDepartment of Urology, Ghent University Hospital, 9000 Ghent, Belgium.ORCID 0000-0002-8513-4985
Sylvie RotteyDepartment of Medical Oncology, Ghent University Hospital, 9000 Ghent, Belgium.

Funding

Roche Diagnostics International AG (Switzerland) KW/1791/ONC/014/013
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

chemoresistancedose-dense MVACmuscle-invasive bladder cancerneoadjuvant chemotherapypathologic complete responsetreatment sequencingtumour immune microenvironmenttumour mutational burden

Identifiers

PMID42738360
PMCPMC13565745

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.